U.S. In Vitro Fertilization Market Size & Outlook, 2026-2033
The in vitro fertilization market in the United States is expected to reach a projected revenue of US$ 8,380.1 million by 2033. A compound annual growth rate of 4.48% is expected of the United States in vitro fertilization market from 2026 to 2033.
Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility
Other key industry trends
In terms of revenue, U.S. accounted for 20.4% of the global in vitro fertilization market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
Mexico is the fastest growing regional market in North America and is projected to reach USD 98.0 million by 2033.
Growth of the U.S. IVF services market is driven by various factors, with one significant factor being the notable increase in infertility rates. Infertility affects a considerable number of couples in the U.S., with approximately one in eight couples experiencing difficulties in conceiving.
According to data from macrotrends.net (2023), the U.S. fertility rate in 2023 was 1.784 births per woman, representing a slight 0.11% increase from the previous year. Various lifestyle factors and behaviors, such as diet, stress, alcohol consumption, obesity, smoking, and Sexually Transmitted Diseases (STDs), can have an impact on fertility rates.
Changes in lifestyle and the prevalence of fertility-related disorders contribute to the rising rates of infertility. As a result, it is expected that the increasing infertility rates will continue to drive market growth in the IVF services sector. A Single Care online survey conducted in February 2021 revealed significant findings regarding the prevalence of infertility in the U.S.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Fresh Nondonor was the largest segment with a revenue share of 48.77% in 2025.
Horizon Databook has segmented the U.S. in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
Growth of the U.S. IVF services market is driven by various factors, with one significant factor being the notable increase in infertility rates. Infertility affects a considerable number of couples in the U.S., with approximately one in eight couples experiencing difficulties in conceiving.
According to data from macrotrends.net (2023), the U.S. fertility rate in 2023 was 1.784 births per woman, representing a slight 0.11% increase from the previous year. Various lifestyle factors and behaviors, such as diet, stress, alcohol consumption, obesity, smoking, and Sexually Transmitted Diseases (STDs), can have an impact on fertility rates.
Changes in lifestyle and the prevalence of fertility-related disorders contribute to the rising rates of infertility. As a result, it is expected that the increasing infertility rates will continue to drive market growth in the IVF services sector. A Single Care online survey conducted in February 2021 revealed significant findings regarding the prevalence of infertility in the U.S.
U.S. In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
Fresh Nondonor
Frozen Nondonor
Fresh Donor
Frozen Donor
U.S. In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
Fertility Clinics
Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. In Vitro Fertilization Market, 2021-2033 (US$M)